The Hair Loss Encyclopedia

Search

for
Search:

GlossaryAnakinra (Kineret)

medication that inhibits interleukin-1 to reduce inflammation

Anakinra is a medication that blocks the activity of interleukin-1 (IL-1), a protein involved in inflammatory responses. It is commonly used to treat conditions like rheumatoid arthritis and certain types of autoinflammatory diseases by reducing inflammation and pain.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 14 results

research Tumor Necrosis Factor-Alpha and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice

53 citations , July 2009 in “Cancer Research”

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

research Data from Tumor Necrosis Factor-Alpha and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice

March 2023

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

research Data from Tumor Necrosis Factor-Alpha and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice

March 2023

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

research North American Clinical Management Guidelines for Hidradenitis Suppurativa: A Publication from the United States and Canadian Hidradenitis Suppurativa Foundations

256 citations , March 2019 in “Journal of the American Academy of Dermatology”

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Commonalities Between COVID-19 and Radiation Injury

research Commonalities Between COVID-19 and Radiation Injury

18 citations , October 2020 in “Radiation Research”

Some drugs may help treat both COVID-19 and radiation injury.

View more "kineret" in research →

Community Join

0 / 0 results

— no results